...Academic Medical Center (AMC) will provide Cernostics with access to a Barrett's esophagus patient registry, which...
...development of esophageal cancer in patients with Barrett's esophagus. Cernostics declined to disclose deal terms. Cernostics Inc....

...Cellumen spun out its personalized medicine unit into Cernostics Pathology Inc. The spinout will provide digital...
...and diagnostics for personalized medicine. Cellumen CEO D. Lansing Taylor will serve as chairman of Cernostics...
...better address market demands and maintain its focus on early drug discovery and toxicity testing. Cernostics’...